163 related articles for article (PubMed ID: 18853950)
1. The effect of sirolimus on prostate-specific antigen (PSA) levels in male renal transplant recipients without prostate cancer.
Chamie K; Ghosh PM; Koppie TM; Romero V; Troppmann C; deVere White RW
Am J Transplant; 2008 Dec; 8(12):2668-73. PubMed ID: 18853950
[TBL] [Abstract][Full Text] [Related]
2. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
3. Results of a prospective randomized trial of sirolimus conversion in kidney transplant recipients on early corticosteroid withdrawal.
Heilman RL; Younan K; Wadei HM; Mai ML; Reddy KS; Chakkera HA; Gonwa TA
Transplantation; 2011 Oct; 92(7):767-73. PubMed ID: 21775930
[TBL] [Abstract][Full Text] [Related]
4. Withdrawal of steroid therapy in African American kidney transplant recipients receiving sirolimus and tacrolimus.
Hricik DE; Knauss TC; Bodziak KA; Weigel K; Rodriguez V; Seaman D; Siegel C; Valente J; Schulak JA
Transplantation; 2003 Sep; 76(6):938-42. PubMed ID: 14508357
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen values and their clinical significance in renal transplant recipients.
Ha R; Jindal RM; Milgrom MM; Leapman SB; Filo RS; Pescovitz MD
South Med J; 1998 Sep; 91(9):847-50. PubMed ID: 9743056
[TBL] [Abstract][Full Text] [Related]
6. Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion and inhibits RORγt and T-bet expression in kidney transplantation.
Jamali S; Sarafnejad A; Ahmadpoor P; Nafar M; Karimi M; Eteghadi A; Yekaninejad MS; Amirzargar AA
Hum Immunol; 2019 Sep; 80(9):739-747. PubMed ID: 30597187
[TBL] [Abstract][Full Text] [Related]
7. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
Gallon LG; Winoto J; Chhabra D; Parker MA; Leventhal JR; Kaufman DB
Transplantation; 2007 May; 83(10):1324-9. PubMed ID: 17519781
[TBL] [Abstract][Full Text] [Related]
8. Belatacept for kidney transplant recipients.
Masson P; Henderson L; Chapman JR; Craig JC; Webster AC
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010699. PubMed ID: 25416857
[TBL] [Abstract][Full Text] [Related]
9. Observations on the use of sirolimus and tacrolimus in high-risk renal transplant recipients.
Lo A; Egidi MF; Gaber LW; Gaber AO
Transplant Proc; 2003 May; 35(3 Suppl):105S-108S. PubMed ID: 12742477
[TBL] [Abstract][Full Text] [Related]
10. De novo cancer avoidance after renal transplantation: A case-control study on low-dose sirolimus combined with a calcineurin inhibitor.
Chen KH; Lee CY; Wu FL; Yang CY; Yeh CC; Hu RH; Tsai MK
J Formos Med Assoc; 2015 Jun; 114(6):526-31. PubMed ID: 25843527
[TBL] [Abstract][Full Text] [Related]
11. Association of Sirolimus Use With Risk for Skin Cancer in a Mixed-Organ Cohort of Solid-Organ Transplant Recipients With a History of Cancer.
Karia PS; Azzi JR; Heher EC; Hills VM; Schmults CD
JAMA Dermatol; 2016 May; 152(5):533-40. PubMed ID: 26792250
[TBL] [Abstract][Full Text] [Related]
12. No-load sirolimus with tacrolimus and steroids is safe and effective in renal transplantation.
Tellis V; Schechner R; Mallis M; Rosegreen S; Glicklich D; Moore N; Greenstein S
Transplant Proc; 2005 Mar; 37(2):906-8. PubMed ID: 15848571
[TBL] [Abstract][Full Text] [Related]
13. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
[TBL] [Abstract][Full Text] [Related]
14. Impact of early conversion from tacrolimus to sirolimus on chronic allograft changes in kidney recipients on rapid steroid withdrawal.
Heilman RL; Cortese C; Geiger XJ; Younan K; Wadei HM; Mai ML; Reddy KS; Gonwa TA
Transplantation; 2012 Jan; 93(1):47-53. PubMed ID: 22067270
[TBL] [Abstract][Full Text] [Related]
15. Kidney transplant histology after one year of continuous therapy with sirolimus compared with tacrolimus.
Dean PG; Grande JP; Sethi S; Park WD; Griffin MD; Cosio FG; Larson TS; Stegall MD
Transplantation; 2008 Apr; 85(8):1212-5. PubMed ID: 18431244
[TBL] [Abstract][Full Text] [Related]
16. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ
Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598
[TBL] [Abstract][Full Text] [Related]
17. Medium-term outcome using sirolimus-tacrolimus combination in adult renal transplant recipients.
Rashid I; El-Sabrout R; Butt F; Delaney V; Qadir M; Hanson P; Butt K
Transplant Proc; 2002 Aug; 34(5):1649-50. PubMed ID: 12176520
[No Abstract] [Full Text] [Related]
18. Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: an analysis of the Scientific Registry of Transplant Recipients Database.
Watt KD; Dierkhising R; Heimbach JK; Charlton MR
Liver Transpl; 2012 Sep; 18(9):1029-36. PubMed ID: 22641474
[TBL] [Abstract][Full Text] [Related]
19. Observations regarding the use of sirolimus and tacrolimus in high-risk cadaveric renal transplantation.
Lo A; Egidi MF; Gaber LW; Shokouh-Amiri MH; Nazakatgoo N; Fisher JS; Gaber AO
Clin Transplant; 2004 Feb; 18(1):53-61. PubMed ID: 15108771
[TBL] [Abstract][Full Text] [Related]
20. Sirolimus use and cancer incidence among US kidney transplant recipients.
Yanik EL; Gustafson SK; Kasiske BL; Israni AK; Snyder JJ; Hess GP; Engels EA; Segev DL
Am J Transplant; 2015 Jan; 15(1):129-36. PubMed ID: 25522018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
